NCT02020031View on ClinicalTrials.gov

Regional Prophylactic Vancomycin in Revision Total Knee Replacement

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Arthropathy of Knee Joint

Interventions

DRUG

Vancomycin

Trial Locations (1)

85054

Mayo Clinic, Phoenix

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Vidacare Corporation

INDUSTRY

lead

Mayo Clinic

OTHER